Use of renin-angiotensin-aldosterone system inhibitors within the first eight to twelve weeks after renal transplantation

Annals of Pharmacotherapy

Volumn 42, Issue 1, 2008, Pages 116-120

  Jennings, Douglas L ^a   Taber, David J ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Angiotensin receptor blockers; Angiotensin converting enzyme inhibitors; Kidney transplant

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCINEURIN INHIBITOR; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; LOSARTAN; NIFEDIPINE; PLASMINOGEN ACTIVATOR INHIBITOR 1; POTASSIUM; QUINAPRIL;

CLINICAL TRIAL; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG EFFICACY; DRUG INDICATION; DRUG INFORMATION; DRUG SAFETY; GRAFT DYSFUNCTION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; KIDNEY FIBROSIS; KIDNEY TRANSPLANTATION; MEDLINE; POSTOPERATIVE PERIOD; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; GRAFT REJECTION; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY TRANSPLANTATION; POSTOPERATIVE PERIOD; PROTEINURIA; RENIN-ANGIOTENSIN SYSTEM; TIME FACTORS;

EID: 38049078344     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1K471     Document Type: Review

References (12)

1. National Collaborating Centre for Chronic Conditions. Hypertension: management in adults in primary care: pharmacological update. London: Royal College of Physicians, 2006. www.nice.org.uk (accessed 2007 May 24).
2. Rosendorff C, Black HR, Cannon CP, et al. Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the councils on clinical cardiology and epidemiology and prevention. Circulation 2007;115:2761-88. DOI 10.1161/CIRCULATIONAHA.107.183885.
3. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 Report. JAMA 2003;289:2560-271. DOI 10.1001/jama.289.19.2560
4. Dagenais GR, Pogue J, Fox K, Simoons ML, Yusuf S. Angiotensin-converting- enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials. Lancet 2006;368:581-8. DOI 10.1016/S0140-6736(06)69201-5.
5. Hou FF, Zhang X, Zhang GH, et al. Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med 2006;354:131-40. DOI 10.1056/NEJMoa053107
6. Ishikawa A, Tanaka M, Ohta N, Ozono S, Kitamura T. Prevention of interstitial fibrosis of renal allograft by angiotensin II blockage. Transplant Proc 2006;38:3498-501. DOI 10.1016/j.transproceed.2006.10.085
7. Heinze G, Collins S, Benedict MA, et al. The association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use during post-ischemic acute transplant failure and renal allograft survival. Transplantation 2006;82:1441-8. DOI 10.1097/01.tp.0000244587.74768.fj
8. Formica RN, Friedman AL, Lorber MI, Bia MJ. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers used in the treatment of hypertension appear to be safe in the early post-transplant period. Transplant Proc 2004;36:2675-8. DOI 10.1097/01.tp.0000244587.74768.f7
9. Lorenz M, Billensteiner M, Bodingbauer M, Oberbauer R, Horl WH, Haas M. The effect of ACE inhibitor and angiotensin II blocker therapy on early post-transplant kidney graft function. Am J Kidney Dis 2004;43:1065-70. DOI 10.1053/j.ajkd.2003.12.058
10. Midvedt K, Hartmann A, Foss A, et al. Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril. Transplantation 2001;72:1787-92. DOI 10.1097/00007890-200112150-00013.
11. Suwelack B, Gerhardt U, Hausberg M, Rahn KH, Hohage H. Comparison of quinapril versus atenolol: effects on blood pressure and cardiac mass after renal transplantation. Am J Cardiol 2000;86:583-5. DOI 10.1016/S0002-9149(00) 01024-9
12. Hausberg M, Barenbrock M, Hohage H, Muller S, Heidenreich S, Rahn KH. ACE inhibitor versus β-blocker for treatment of hypertension in renal allograft recipients. Hypertension 1999;33:862-8.